Variant sequences: the new frontier in sequence IP

A variant sequence is typically a naturally-occurring molecule, most frequently protein, which has been modified in order to impart desired characteristics such as improved stability under anticipated use conditions, or increased activity. Optimising sequences and, of course, the associated IP rights, span most areas of biotechnology.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

MedTech

Insulet asks Fed Circ to rehear $59.4m trade secret reversal

3 August 2026 The medical device maker says that a split appellate decision raises broader questions about trade secret law, jurisdiction and when the clock starts ticking on misappropriation claims.

Careers

Arnold & Porter adds firepower to ITC practice with new partner hire

3 August 2026 Appointment strengthens the firm’s expertise in US International Trade Commission proceedings and cross-border intellectual property disputes.

Pharma

USPTO director steps into Sun Pharma’s PTAB-ITC clash

31 July 2026 A director review has overturned a PTAB ruling, questioning why it diverged from an ITC decision based on the same patent claims, prior art and evidence.

More features

USPTO director steps into Sun Pharma’s PTAB-ITC clash

European court strikes down hearing aid sensor patent

Boston Scientific overturns $42m patent verdict on appeal

Pharmascience v Janssen: Canada court updates methods of medical treatment protection

Why is 2026 already a record year for M&A activity?

Illumina ordered to recall products after German patent ruling

Goodwin launches San Diego office with senior life sciences hire

Sanofi launches mRNA vaccine lawsuits at Moderna and Pfizer

Variant sequences: the new frontier in sequence IP

More on this story

Editor's picks

Editor's picks

More features